JMP Securities Reiterates Market Outperform on Relay Therapeutics, Maintains $24 Price Target

Benzinga · 05/06 15:07
JMP Securities analyst Silvan Tuerkcan reiterates Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and maintains $24 price target.